Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

GSK1324726A

Copy Product Info
😃Good
Catalog No. T6021Cas No. 1300031-52-0
Alias I-BET726

GSK1324726A (I-BET726) is a greatly specific inhibitor of BET family proteins for BRD2(IC50=41 nM), BRD3(IC50=31 nM), and BRD4 (IC50=22 nM).

GSK1324726A

GSK1324726A

Copy Product Info
😃Good
Purity: 99.85%
Catalog No. T6021Alias I-BET726Cas No. 1300031-52-0
GSK1324726A (I-BET726) is a greatly specific inhibitor of BET family proteins for BRD2(IC50=41 nM), BRD3(IC50=31 nM), and BRD4 (IC50=22 nM).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$44In StockIn Stock
10 mg$71In StockIn Stock
25 mg$143In StockIn Stock
50 mg$213In StockIn Stock
100 mg$320In StockIn Stock
200 mg$448-In Stock
1 mL x 10 mM (in DMSO)$48In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.85%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
GSK1324726A (I-BET726) is a greatly specific inhibitor of BET family proteins for BRD2(IC50=41 nM), BRD3(IC50=31 nM), and BRD4 (IC50=22 nM).
Targets&IC50
BRD2:41 nM, BRD3:31 nM, BRD4:22 nM
In vitro
In the mouse models SK-N-AS and CHP-212, GSK1324726A administered at 15 mg/kg orally (o.p.) was effective in inhibiting tumor growth and downregulating the expression of MYCN and BCL2. Additionally, at a dosage of 10 mg/kg intravenously (i.v.), GSK1324726A demonstrated potent anti-inflammatory effects and prevented mortality in mice experiencing septic shock.
In vivo
In neuroblastoma cell lines, GSK1324726A inhibits cell growth and induces cytotoxicity. It regulates the expression of genes in the MYC family pathway, including direct expression of BCL2 and MYCN.
Kinase Assay
Determination of BET Protein Binding Affinities to I-BET726: For determination of binding affinities to BET protein bromodomains, I-BET726 is titrated against truncates containing both BD1 and BD2 of BRD2 (10 nM), BRD3 (10 nM), and BRD4 (10 nM) in 50 mM HEPES pH7.5, 150 mM NaCl, 5% Glycerol, 1 mM DTT and 1 mM CHAPS in the presence of an Alexa 647 derivative (50 nM) of fluorescent ligand. After equilibrating for 1 h, the bromodomain protein: ligand interaction is detected using Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) following the addition of 1.5 nM europium chelate labeled anti-6His antibody. Plates are read using an Envision Plate reader (λEX = 337 nm, λEM = 615 nm, λEM = 665 nm; dual dichroic = 400 nm & 630 nm). These data are fitted to a four parameter IC50 model using Graphit data analysis software.
Cell Research
Briefly, cells are seeded into 384-well or 96-well plates at a density optimized for 6 days of growth. The following day, T0 measurements are taken using CellTiter-Glo, CellTiter-Fluor, or CyQuant Direct, following the manufacturer's instructions. Plates are read on an Envision, Safire 2, or SpectraMax Gemini EM plate reader. Remaining plates are treated with DMSO or a titration of I-BET726. Cells are incubated for 6 days and developed as described above. Results are plotted as a percentage of the T0 value, normalized to 100%, versus concentration of compound. A 4-parameter equation is used to generate concentration response curves. Growth IC50 (gIC50) values are calculated at the mid-point of the growth window (between DMSO and T0 values). Ymin-T0 values are calculated by subtracting the T0 value (100%) from the Ymin value on the curve, and are a measure of net population cell growth or death.(Only for Reference)
SynonymsI-BET726
Chemical Properties
Molecular Weight434.91
FormulaC25H23ClN2O3
Cas No.1300031-52-0
SmilesC(C)(=O)N1C=2C([C@H](NC3=CC=C(Cl)C=C3)C[C@@H]1C)=CC(=CC2)C4=CC=C(C(O)=O)C=C4
Relative Density.1.304 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50 mg/mL (114.97 mM), Sonication is recommended.
Ethanol: 80 mg/mL (183.95 mM), Sonication is recommended.
H2O: < 1 mg/mL (insoluble or slightly soluble)
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.6 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO/Ethanol
1mg5mg10mg50mg
1 mM2.2993 mL11.4966 mL22.9933 mL114.9663 mL
5 mM0.4599 mL2.2993 mL4.5987 mL22.9933 mL
10 mM0.2299 mL1.1497 mL2.2993 mL11.4966 mL
20 mM0.1150 mL0.5748 mL1.1497 mL5.7483 mL
50 mM0.0460 mL0.2299 mL0.4599 mL2.2993 mL
100 mM0.0230 mL0.1150 mL0.2299 mL1.1497 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy GSK1324726A | purchase GSK1324726A | GSK1324726A cost | order GSK1324726A | GSK1324726A chemical structure | GSK1324726A in vivo | GSK1324726A in vitro | GSK1324726A formula | GSK1324726A molecular weight